Augmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health Assets

Augmedics, a pioneer in augmented reality (AR) surgical navigation, announced it has been named the successful bidder for the digital health assets of Surgalign and Holo Surgical following a competitive auction process. The news comes a month following Augmedics’ $82.5 million raise to accelerate the adoption of augmented reality spine surgery and further strengthens the company’s AR and AI portfolio with intellectual property and other digital health assets.

Read More about InterviewI : AiThority Interview with Alistair Dent, Chief Strategy Officer at Profusion

“We are pleased to further expand our strong technical and intellectual property position in the field of augmented reality surgery with this planned acquisition”

“We are pleased to further expand our strong technical and intellectual property position in the field of augmented reality surgery with this planned acquisition,” said Augmedics President & CEO Kevin Hykes. “Augmedics shares Surgalign’s passion for developing cutting-edge technology in the name of improved surgical outcomes. We look forward to leveraging these assets to further evolve the xvision platform.”

Browse more about Interview Insights: AiThority Interview: Top AI and ML Trends Transforming the Customer Service Industry

Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company’s revolutionary xvision Spine System® allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 4,000 patients and implant more than 20,000 pedicle screws across 21 US states. xvision has consistently demonstrated 97-100% accuracy of pedicle screw placement across multiple patient studies.

 Latest Interview Insights : AiThority Interview with Gary Kotovets, Chief Data and Analytics Officer at Dun & Bradstreet

 [To share your insights with us, please write to sghosh@martechseries.com]